Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of down syndrome.

A mouse model for Down syndrome exhibits learning and behaviour deficits

Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913 · see citing works

Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

Costa, R. M., Federov, N. B., Kogan, J. H., Murphy, G. G., Stern, J. N. H., Ohno, M., Kucherlapati, R., Jacks, T., & Silva, A. J. (2002) · Nature · doi:10.1038/nature711 · Cited by 586 · see citing works

The neuropsychology of down syndrome: evidence for hippocampal dysfunction.

Pennington, B. F., Moon, J., Edgin, J., Stedron, J., & Nadel, L. (2003) · Child Development · doi:10.1111/1467-8624.00522 · Cited by 514 · see citing works

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-04.2004 · Cited by 459 · see citing works

Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome

Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13333 · Cited by 448 · see citing works

Strain-dependent Differences in LTP and Hippocampus-dependent Memory in Inbred MicePreprint

Nguyen, P., Abel, T. G., Kandel, E. R., & Bourtchouladze, R. (2000) · Learning & Memory · doi:10.1101/lm.7.3.170 · Cited by 237 · see citing works

A behavioral assessment of Ts65Dn mice: a putative Down syndrome model

Escorihuela, R. M., Fernández‐Teruel, A., Vallina, I. F., Baamonde, C., Lumbreras, M., Dierssen, M., Tobeña, A., & Flórez, J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12052-6 · Cited by 234 · see citing works

Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's Syndrome

Granholm, A., Sanders, L., & Crnic, L. S. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7289 · Cited by 229 · see citing works

Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome

Siarey, R. J., Stoll, J., Rapoport, S. I., & Galdzicki, Z. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00157-3 · Cited by 222 · see citing works

MRI volumes of the hippocampus and amygdala in adults with Down’s syndrome with and without dementia

Aylward, E. H., Li, Q., Honeycutt, N. A., Warren, A. C., Pulsifer, M. B., Barta, P. E., Chan, M. D., Smith, P. D., Jerram, M., & Pearlson, G. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.564 · Cited by 217 · see citing works

Down syndrome and genetics — a case of linked histories

Patterson, D., & Costa, A. C. S. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1525 · Cited by 208 · see citing works

Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions

Gardiner, K., Fortna, A., Bechtel, L. J., & Davisson, M. T. (2003) · Gene · doi:10.1016/s0378-1119(03)00769-8 · Cited by 203 · see citing works

Amygdala and hippocampal volumes in children with Down syndrome: A high-resolution MRI study

Pinter, J. D., Brown, W. E., D, S. E. M., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001) · Neurology · doi:10.1212/wnl.56.7.972 · Cited by 197 · see citing works

Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome

Siarey, R. J., Carlson, E. J., Epstein, C. J., Balbo, A., Rapoport, S. I., & Galdzicki, Z. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00083-0 · Cited by 184 · see citing works

Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of down syndrome.

Insausti, A. M., Megı́as, M., Crespo, D., Cruz-Orive, L. M., Dierssen, M., Vallina, T. F., Insausti, R., & Flórez, J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00641-7 · Cited by 149 · see citing works

Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome

Richtsmeier, J. T., Zumwalt, A., Carlson, E. J., Epstein, C. J., & Reeves, R. H. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10175 · Cited by 142 · see citing works

Behavioral comparison of 4 and 6 month-old Ts65Dn mice:

Hunter, C. L., Bimonte, H. A., & Granholm, A. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00275-9 · Cited by 112 · see citing works

Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome

Hampton, T. G., Stasko, M. R., Kale, A., Amende, I., & Costa, A. C. S. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.04.006 · Cited by 108 · see citing works

Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice

Demas, G. E., Nelson, R. J., Krueger, B. K., & Yarowsky, P. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00116-2 · Cited by 98 · see citing works

Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome

Stasko, M. R., & Costa, A. C. S. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.01.012 · Cited by 79 · see citing works

Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.

Hyde, L. A., & Crnic, L. S. (2001) · Behavioral Neuroscience · doi:10.1037/0735-7044.115.6.1239 · Cited by 77 · see citing works

Long-term potentiation persistence greater in C57BL/6 than DBA/2 mice: Predicted on basis of protein kinase C levels and learning performance

Matsuyama, S., Namgung, U., & Routtenberg, A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00444-7 · Cited by 65 · see citing works

Facilitated CA1 hippocampal synaptic plasticity in dystrophin‐deficient mice: Role for GABAA receptors?

Vaillend, C., & Billard, J. (2002) · Hippocampus · doi:10.1002/hipo.10068 · Cited by 63 · see citing works

Differential induction of long-lasting potentiation of inhibitory postsynaptic potentials by theta patterned stimulation versus 100-Hz tetanization in hippocampal pyramidal cells in vitro

Perez, Y., Chapman, C. A., Woodhall, G. L., Robitaille, R., & Lacaille, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00531-4 · Cited by 42 · see citing works

Mechanisms of presynaptic inhibition studied using paired-pulse facilitation

Stuart, G. J., & Redman, S. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90548-8 · Cited by 35 · see citing works

Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., & Garner, C. C. (2007) · Nature Neuroscience · doi:10.1038/nn1860 · Cited by 509 · see citing works

Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome

Deidda, G., Parrini, M., Naskar, S., Bozarth, I. F., Contestabile, A., & Cancedda, L. (2015) · Nature Medicine · doi:10.1038/nm.3827 · Cited by 268 · see citing works

Olig1 and Olig2 triplication causes developmental brain defects in down syndrome.

Chakrabarti, L., Best, T. K., Cramer, N. P., Carney, R. S. E., Isaac, J. T. R., Galdzicki, Z., & Haydar, T. F. (2010) · Nature Neuroscience · doi:10.1038/nn.2600 · Cited by 258 · see citing works

A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions

Yu, T., Li, Z., Jia, Z., Clapcote, S. J., Liu, C., Li, S., Asrar, S., Pao, A., Chen, R., Fan, N., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq179 · Cited by 238 · see citing works

Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome

Duchon, A., Raveau, M., Chevalier, C., Nalesso, V., Sharp, A. J., & Herault, Y. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9356-0 · Cited by 224 · see citing works

DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects

Ahn, K.-J., Jeong, H. K., Choi, H.-S., Ryoo, S.-R., Kim, Y. J., Goo, J.-S., Choi, S.-Y., Han, J.-S., Ha, I., & Song, W.-J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.006 · Cited by 220 · see citing works

The role of GABAergic signalling in neurodevelopmental disorders

Tang, X., Jaenisch, R., & Sur, M. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00443-x · Cited by 206 · see citing works

Synaptic and cognitive abnormalities in mouse models of down syndrome: Exploring genotype‐phenotype relationships

Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Epstein, C. J., & Mobley, W. C. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21433 · Cited by 202 · see citing works

The “Down Syndrome Critical Region” Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down Syndrome

Belichenko, N. P., Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Reeves, R. H., & Mobley, W. C. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1547-09.2009 · Cited by 201 · see citing works

Rodent models in Down syndrome research: impact and future opportunities

Hérault, Y., Delabar, J. M., Fisher, E., Tybulewicz, V. L. J., Yu, E. Y., & Brault, V. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029728 · Cited by 191 · see citing works

OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome

Xu, R., Brawner, A. T., Li, S., Liu, J.-J., Kim, H., Xue, H., Pang, Z. P., Kim, W.-Y., Hart, R. P., Liu, Y., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.014 · Cited by 193 · see citing works

Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives

Deidda, G., Bozarth, I. F., & Cancedda, L. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00119 · Cited by 192 · see citing works

DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in down syndrome

Duchon, A., & Herault, Y. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00104 · Cited by 181 · see citing works

Trisomy for the Down syndrome ‘critical region’ is necessary but not sufficient for brain phenotypes of trisomic mice

Olson, L. E., Roper, R. J., Sengstaken, C. L., Peterson, E. A., Aquino, V. N., Galdzicki, Z., Siarey, R. J., Pletnikov, M. V., Moran, T. H., & Reeves, R. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm022 · Cited by 178 · see citing works

Deficits in Cognition and Synaptic Plasticity in a Mouse Model of Down Syndrome Ameliorated by GABAB Receptor Antagonists

Kleschevnikov, A. M., Belichenko, P. V., Faizi, M., Jacobs, L. F., Htun, K. E., Shamloo, M., & Mobley, W. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1673-12.2012 · Cited by 174 · see citing works

Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities

Rueda, N., Flórez, J., & Martínez-Cué, C. (2012) · Neural Plasticity · doi:10.1155/2012/584071 · Cited by 171 · see citing works

Long-Term Potentiation at CA3–CA1 Hippocampal Synapses with Special Emphasis on Aging, Disease, and Stress

Kumar, A. (2011) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2011.00007 · Cited by 169 · see citing works

Acute Injections of the NMDA Receptor Antagonist Memantine Rescue Performance Deficits of the Ts65Dn Mouse Model of Down Syndrome on a Fear Conditioning Test

Costa, A. C. S., Scott-McKean, J. J., & Stasko, M. R. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301535 · Cited by 163 · see citing works

Reducing GABA A α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome

Martínez‐Cué, C., Martinez, P. M., Rueda, N., Vidal, R., García-Cerro, S., Vidal, V., Corrales, A., Montero, J. A., Pazos, Á., Flórez, J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1203-12.2013 · Cited by 154 · see citing works

Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome

Clark, S. M., Schwalbe, J., Stasko, M. R., Yarowsky, P., & Costa, A. C. S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.005 · Cited by 142 · see citing works

The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome

Contestabile, A., Magara, S., & Cancedda, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00054 · Cited by 141 · see citing works

Communication breaks-Down: From neurodevelopment defects to cognitive disabilities in Down syndrome

Contestabile, A., Benfenati, F., & Gasparini, L. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.003 · Cited by 134 · see citing works

Hedgehog Agonist Therapy Corrects Structural and Cognitive Deficits in a Down Syndrome Mouse Model

Das, I., Park, J. M., Shin, J. H., Jeon, S. K., Lorenzi, H., Linden, D. J., Worley, P. F., & Reeves, R. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005983 · Cited by 134 · see citing works

Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice

Yu, T., Liu, C., Belichenko, P., Clapcote, S. J., Li, S., Pao, A., Kleschevnikov, A., Bechard, A. R., Asrar, S., Chen, R., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.107 · Cited by 127 · see citing works

Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome

Rueda, N., Flórez, J., & Martínez‐Cué, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.039 · Cited by 127 · see citing works

A new mouse model for the trisomy of the Abcg1–U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome

Pereira, P. L., Magnol, L., Sahún, I., Brault, V., Duchon, A., Prandini, P., Gruart, A., Bizot, J., Chadefaux, B., Deutsch, S., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp438 · Cited by 125 · see citing works

Timing of therapies for Down syndrome: the sooner, the better

Stagni, F., Giacomini, A., Guidi, S., Ciani, E., & Bartesaghi, R. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00265 · Cited by 122 · see citing works

Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Gall, J., George, L., Nosheny, R., Maloney, M. T., Salehi, A., & Mobley, W. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.009 · Cited by 124 · see citing works

Ts65Dn, a Mouse Model of Down Syndrome, Exhibits Increased GABAB-Induced Potassium Current

Best, T. K., Siarey, R. J., & Galdzicki, Z. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00626.2006 · Cited by 117 · see citing works

Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations

Gardiner, K. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s51476 · Cited by 114 · see citing works

The use of mouse models to understand and improve cognitive deficits in Down syndrome

Das, I., & Reeves, R. H. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007716 · Cited by 99 · see citing works

Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndromePreprint

Morice, É., Andreae, L. C., Cooke, S. F., Vanes, L., Fisher, E., Tybulewicz, V. L. J., & Bliss, T. (2008) · Learning & Memory · doi:10.1101/lm.969608 · Cited by 97 · see citing works

The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome

Hanson, J. E., Blank, M., Valenzuela, R. A., Garner, C. C., & Madison, D. V. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.114868 · Cited by 94 · see citing works

Impairments in motor coordination without major changes in cerebellar plasticity in the Tc1 mouse model of Down syndrome

Galante, M., Jani, H., Vanes, L., Daniel, H., Fisher, E., Tybulewicz, V. L. J., Bliss, T. V. P., & Morice, É. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp055 · Cited by 89 · see citing works

Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system

Jeremic, D., Sanchez-Rodriguez, I., Jimenez-Diaz, L., & Navarro-Lopez, J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107808 · Cited by 89 · see citing works

Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome

Siarey, R. J., Kline‐Burgess, A., Cho, M., Balbo, A., Best, T. K., Harashima, C., Klann, E., & Galdzicki, Z. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03971.x · Cited by 86 · see citing works

Rho GTPases in Intellectual Disability: From Genetics to Therapeutic Opportunities

Zamboni, V., Jones, R., Umbach, A., Ammoni, A., Passafaro, M., Hirsch, E., & Merlo, G. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061821 · Cited by 83 · see citing works

Antioxidants in Down syndrome

Lott, I. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.010 · Cited by 82 · see citing works

Prospects for Improving Brain Function in Individuals with Down Syndrome

Costa, A. C. S., & Scott-McKean, J. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0089-3 · Cited by 81 · see citing works

Molecular basis of pharmacotherapies for cognition in Down syndrome

Gardiner, K. (2009) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.10.010 · Cited by 113 · see citing works

Trisomy of the G protein-coupled K + channel gene, Kcnj6 , affects reward mechanisms, cognitive functions, and synaptic plasticity in mice

Cooper, A., Grigoryan, G., Guy-David, L., Tsoory, M., Chen, A., & Reuveny, E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109099109 · Cited by 78 · see citing works

Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome

Best, T. K., Cramer, N., Chakrabarti, L., Haydar, T. F., & Galdzicki, Z. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.033 · Cited by 74 · see citing works

Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome

Parrini, M., Ghezzi, D., Deidda, G., Medrihan, L., Castroflorio, E., Alberti, M., Baldelli, P., Cancedda, L., & Contestabile, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17201-8 · Cited by 73 · see citing works

Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues

Belichenko, P. V., Kleschevnikov, A. M., Becker, A., Wagner, G. E., Lysenko, L. V., Yu, Y. E., & Mobley, W. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134861 · Cited by 70 · see citing works

Using mouse models to explore genotype–phenotype relationship in Down syndrome

Salehi, A., Faizi, M., Belichenko, P. V., & Mobley, W. C. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20164 · Cited by 70 · see citing works

Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome

Begenisic, T., Baroncelli, L., Sansevero, G., Milanese, M., Bonifacino, T., Bonanno, G., Cioni, G., Maffei, L., & Sale, A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.010 · Cited by 66 · see citing works

Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice

Mans, R. A., Chowdhury, N., Cao, D., McMahon, L. L., & Li, L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.062 · Cited by 67 · see citing works

Short‐term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro‐cognitive benefit in a mouse model of D own's syndrome

Colas, D., Chuluun, B., Warrier, D. R., Blank, M., Wetmore, D. Z., Buckmaster, P. S., Garner, C. C., & Heller, H. C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12169 · Cited by 63 · see citing works

GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome

Martín, J. Z. D. S., Delabar, J. M., Bacci, A., & Potier, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.002 · Cited by 64 · see citing works

Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models

Souchet, B., Duchon, A., Gu, Y., Dairou, J., Chevalier, C., Daubigney, F., Nalesso, V., Créau, N., Yu, Y., Janel, N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40328-9 · Cited by 54 · see citing works

Treating enhanced GABAergic inhibition in Down syndrome: Use of GABA α5-selective inverse agonists

Martínez-Cué, C., Delatour, B., & Potier, M.-C. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.12.008 · Cited by 58 · see citing works

GluN2B Antagonism Affects Interneurons and Leads to Immediate and Persistent Changes in Synaptic Plasticity, Oscillations, and Behavior

Hanson, J. E., Weber, M., Meilandt, W. J., Wu, T. Z., Luu, T., Deng, L., Shamloo, M., Sheng, M., Scearce-Levie, K. A., & Zhou, Q. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.19 · Cited by 55 · see citing works

From Abnormal Hippocampal Synaptic Plasticity in Down Syndrome Mouse Models to Cognitive Disability in Down Syndrome

Cramer, N., & Galdzicki, Z. (2012) · Neural Plasticity · doi:10.1155/2012/101542 · Cited by 54 · see citing works

Emerging Pharmacotherapies for Neurodevelopmental Disorders

Wetmore, D. Z., & Garner, C. C. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181ee3833 · Cited by 54 · see citing works

Promotion of Neuronal Plasticity by (−)-Epigallocatechin-3-Gallate

Xie, W. Q., Ramakrishna, N., Wieraszko, A., & Hwang, Y. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9494-7 · Cited by 50 · see citing works

The Down Syndrome Critical Region Regulates Retinogeniculate Refinement

Blank, M., Fuerst, P. G., Stevens, B., Nouri, N., Kirkby, L. A., Warrier, D. R., Barres, B. A., Feller, M. B., Huberman, A. D., Burgess, R. W., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6015-10.2011 · Cited by 51 · see citing works

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of D own syndrome

Corrales, A., Vidal, R., García-Cerro, S., Vidal, V., Martinez, P. M., García, E., Flórez, J., Sánchez‐Barceló, E. J., Martínez‐Cué, C., & Rueda, N. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12097 · Cited by 51 · see citing works

Pathways to cognitive deficits in Down syndrome

Sturgeon, X., Le, T., Ahmed, M. M., & Gardiner, K. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00005-4 · Cited by 51 · see citing works

GABAB–GIRK2-Mediated Signaling in Down Syndrome

Cramer, N., Best, T. K., Stoffel, M., Siarey, R. J., & Galdzicki, Z. (2010) · Advances in pharmacology · doi:10.1016/s1054-3589(10)58015-3 · Cited by 49 · see citing works

In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model

Chen, Y., Dyakin, V. V., Branch, C. A., Ardekani, B. A., Yang, D., Guilfoyle, D. N., Peterson, J. N., Peterhoff, C. M., Ginsberg, S. D., Cataldo, A. M., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.026 · Cited by 49 · see citing works

Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease

Scott-McKean, J. J., Surewicz, K. A., Choi, J.-K., Ruffin, V. A., Salameh, A., Nieznański, K., Costa, A. C. S., & Surewicz, W. K. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.001 · Cited by 49 · see citing works

Down syndrome

Rafii, M. S., Kleschevnikov, A. M., Sawa, M., & Mobley, W. C. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00017-0 · Cited by 52 · see citing works

Three‐dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of down syndrome

Popov, V. I., Kleschevnikov, A. M., Klimenko, O. A., Stewart, M. G., & Belichenko, P. V. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22573 · Cited by 48 · see citing works

Neurodevelopment in Down syndrome: Concordance in humans and models

Klein, J. A., & Haydar, T. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.941855 · Cited by 47 · see citing works

Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome

Chang, Q., & Gold, P. E. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.05.007 · Cited by 46 · see citing works

Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantinePreprint

Scott-McKean, J. J., & Costa, A. C. S. (2011) · Learning & Memory · doi:10.1101/lm.024182.111 · Cited by 44 · see citing works

On the Promise of Pharmacotherapies Targeted at Cognitive and Neurodegenerative Components of Down Syndrome

Costa, A. C. S. (2011) · Developmental Neuroscience · doi:10.1159/000330861 · Cited by 44 · see citing works

The kinesin superfamily protein KIF17: one protein with many functions

Wong‐Riley, M. T. T., & Besharse, J. C. (2012) · BioMolecular Concepts · doi:10.1515/bmc-2011-0064 · Cited by 42 · see citing works

Enhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome

Schulz, J. M., Knoflach, F., Hernandez, M., & Bischofberger, J. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2723-18.2019 · Cited by 39 · see citing works

Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.

Rachidi, M., & Lopes, C. (2010) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-115.2.83 · Cited by 36 · see citing works

Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome

Rueda, N., Flórez, J., & Martínez‐Cué, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.020 · Cited by 39 · see citing works

Impact of the Olig Family on Neurodevelopmental Disorders

Szu, J., Wojcinski, A., Jiang, P., & Kesari, S. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.659601 · Cited by 36 · see citing works

The α5-Containing GABAA Receptors—a Brief Summary

Mohamad, F. H., & Has, A. T. C. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1246-4 · Cited by 38 · see citing works

Modeling Down syndrome in animals from the early stage to the 4.0 models and next

Moreno, M. D. M. M., Brault, V., Birling, M., Pavlovic, G., & Hérault, Y. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2019.08.001 · Cited by 32 · see citing works

Signalling pathways contributing to learning and memory deficits in the Ts65Dn mouse model of Down syndrome

Freeburn, A., & Munn, R. G. K. (2021) · Neuronal Signaling · doi:10.1042/ns20200011 · Cited by 37 · see citing works

Perturbation of dendritic protrusions in intellectual disability

Levenga, J., & Willemsen, R. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00008-x · Cited by 37 · see citing works

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome

Navarro-Romero, A., Vázquez‐Oliver, A., Gomis‐González, M., Garzón-Montesinos, C., Falcón‐Moya, R., Pastor, A., Martín‐García, E., Pizarro, N., Busquets-García, A., Revest, J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.014 · Cited by 35 · see citing works

Targeting redox-altered plasticity to reactivate synaptic function: A novel therapeutic strategy for cognitive disorder

Wang, P., Wang, F., Ni, L., Wu, P., & Chen, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.012 · Cited by 37 · see citing works

Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer’s Disease

Alldred, M. J., Penikalapati, S. C., Lee, S. H., Heguy, A., Roussos, P., & Ginsberg, S. D. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02453-3 · Cited by 36 · see citing works

Early environmental therapy rescues brain development in a mouse model of Down syndrome

Begenisic, T., Sansevero, G., Baroncelli, L., Cioni, G., & Sale, A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.014 · Cited by 34 · see citing works

Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome

Parrini, M., Naskar, S., Alberti, M., Colombi, I., Morelli, G., Rocchi, A., Nanni, M., Piccardi, F., Charles, S., Ronzitti, G., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.023 · Cited by 33 · see citing works

The in vivo Down syndrome genomic library in mouse

Hérault, Y., Duchon, A., Velot, É., Maréchal, D., & Brault, V. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00009-1 · Cited by 32 · see citing works

Synaptic Pathology of Down Syndrome

Garner, C. C., & Wetmore, D. Z. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_20 · Cited by 33 · see citing works

Unbalanced dendritic inhibition of CA1 neurons drives spatial-memory deficits in the Ts2Cje Down syndrome model

Valbuena, S., García, Á., Mazier, W., Paternain, A. V., & Lerma, J. (2019) · Nature Communications · doi:10.1038/s41467-019-13004-9 · Cited by 32 · see citing works

Interneuron deficits in neurodevelopmental disorders: Implications for disease pathology and interneuron-based therapies

Paternò, R., Casalia, M. L., & Baraban, S. C. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.015 · Cited by 32 · see citing works

The Mouse Model of Down Syndrome Ts65Dn Presents Visual Deficits as Assessed by Pattern Visual Evoked Potentials

Scott-McKean, J. J., Chang, B., Hurd, R. E., Nusinowitz, S., Schmidt, C., Davisson, M. T., & Costa, A. C. S. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4465 · Cited by 31 · see citing works

Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome

Rueda, N., Flórez, J., Dierssen, M., & Martínez‐Cué, C. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.001 · Cited by 29 · see citing works

Roles for DSCAM and DSCAML1 in central nervous system development and disease.

Montesinos, M. (2014) · Advances in neurobiology · doi:10.1007/978-1-4614-8090-7_11 · Cited by 32 · see citing works

Mechanism based approaches for rescuing and enhancing cognition

LYNCH, G. S. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00143 · Cited by 30 · see citing works

Discoveries in Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Salehi, A., & Wu, C. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00010-8 · Cited by 29 · see citing works

Mouse models of cognitive disabilities in trisomy 21 (Down syndrome)

Roubertoux, P. L., & Carlier, M. (2010) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30280 · Cited by 28 · see citing works

Object recognition memory is conserved in Ts1Cje, a mouse model of Down syndrome

Fernandez, F., & Garner, C. C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.075 · Cited by 28 · see citing works

Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer’s-like memory deficits in the Ts65Dn mouse model of Down syndrome

Kazim, S. F., Blanchard, J., Bianchi, R., & Iqbal, K. (2017) · Scientific Reports · doi:10.1038/srep45561 · Cited by 28 · see citing works

Brain circuit pathology in Down syndrome: from neurons to neural networks

Bartesaghi, R. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0067 · Cited by 25 · see citing works

DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in Down syndrome mouse models

Liu, H., Caballero-Florán, R. N., Hergenreder, T., Yang, T., Hull, J. M., Pan, G., Li, R., Veling, M. W., Isom, L. L., Kwan, K. Y., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002078 · Cited by 25 · see citing works

Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors

Cunha‐Reis, D., Aidil-Carvalho, M. F., & Ribeiro, J. A. (2014) · Hippocampus · doi:10.1002/hipo.22316 · Cited by 24 · see citing works

Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome

Borralleras, C., Mato, S., Amédée, T., Matute, C., Mulle, C., Jurado, L. A. P., & Campuzano, V. (2016) · Molecular Brain · doi:10.1186/s13041-016-0258-7 · Cited by 24 · see citing works

Physical Exercise Modulates Brain Physiology Through a Network of Long- and Short-Range Cellular Interactions

Consorti, A., Marco, I. D., & Sansevero, G. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.710303 · Cited by 25 · see citing works

Normal protein composition of synapses in Ts65Dn mice: a mouse model of Down syndrome

Fernandez, F., Trinidad, J. C., Blank, M., Feng, D., Burlingame, A. L., & Garner, C. C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06110.x · Cited by 22 · see citing works

The role of DSCAM in the regulation of synaptic plasticity: possible involvement in neuropsychiatric disorders

Stachowicz, K. (2018) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2018-019 · Cited by 23 · see citing works

Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome

Siarey, R. J., Stoll, J., Rapoport, S. I., & Galdzicki, Z. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00157-3 · Cited by 222 · see citing works

Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome

Siarey, R. J., Carlson, E. J., Epstein, C. J., Balbo, A., Rapoport, S. I., & Galdzicki, Z. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00083-0 · Cited by 184 · see citing works

Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down Syndrome

Scott-McKean, J. J., Roque, A. L., Surewicz, K. A., Johnson, M. W., Surewicz, W. K., & Costa, A. C. S. (2018) · Neural Plasticity · doi:10.1155/2018/9235796 · Cited by 19 · see citing works

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome

Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-04.2004 · Cited by 459 · see citing works

Assignment of the Human Glutamate Receptor Gene GLUR5 to 21q22 by Screening a Chromosome 21 YAC Library

Potier, M., Dutriaux, A., Lambolez, B., Bochet, P., & Rossier, J. (1993) · Genomics · doi:10.1006/geno.1993.1131 · Cited by 12 · see citing works